New Rx Diet Drug Approval Crowds Market
Contrave, a diet drug by Orexigen, has received a recommendation for European approval. Orexigen will change the brand name of Contrave to Mysimba for marketing in Europe, once final approval is granted early next year. The other new diet drugs, Belviq and Qsymia, have not been big sellers – considering that more than a third of […]
New Rx Diet Drug Approval Crowds Market Read More »